2026年9月13日•3分で読めます
CGRP-Targeted Migraine Drugs Expand in Korea with New Formulations
CGRP-based migraine therapies are rapidly entering the Korean market, offering injectable and oral options that diversify treatment beyond traditional CNS‑active drugs.